scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1045042796 |
P356 | DOI | 10.1186/AR3881 |
P932 | PMC publication ID | 3446531 |
P698 | PubMed publication ID | 22697500 |
P5875 | ResearchGate publication ID | 225372895 |
P50 | author | Elias Toubi | Q73738307 |
P2093 | author name string | Zahava Vadasz | |
Gleb Slobodin | |||
Itzhak Rosner | |||
Aharon Kessel | |||
Dina Attias | |||
Gera Neufeld | |||
Ofra Kessler | |||
Katalin Halasz | |||
Tharwat Haj | |||
P2860 | cites work | Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates | Q22010646 |
Neuropilin is a semaphorin III receptor | Q24310629 | ||
Mechanisms of foxp3+ T regulatory cell-mediated suppression | Q29615842 | ||
Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells | Q33372124 | ||
Regulation of immune cell responses by semaphorins and their receptors | Q33827421 | ||
Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm | Q34420865 | ||
Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis | Q34550001 | ||
The semaphorins | Q35012897 | ||
Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions | Q35720424 | ||
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor | Q36478465 | ||
Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity | Q36825006 | ||
Semaphorins and their receptors in immune cell interactions. | Q37034914 | ||
Neuropilin-1: the glue between regulatory T cells and dendritic cells? | Q37110402 | ||
Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity | Q37693713 | ||
Neuropilins and semaphorins — from angiogenesis to autoimmunity | Q37777210 | ||
The role of immune semaphorins in multiple sclerosis | Q37855196 | ||
More than nervous: the emerging roles of plexins | Q37958205 | ||
Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages | Q39845354 | ||
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. | Q40040903 | ||
Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition | Q41902497 | ||
Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell | Q43249326 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. | Q51039778 | ||
Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. | Q53200046 | ||
The involvement of immune semaphorins and neuropilin-1 in lupus nephritis. | Q53216735 | ||
The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. | Q54407326 | ||
Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization | Q57218312 | ||
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response | Q57218726 | ||
Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? | Q64461677 | ||
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function | Q82097189 | ||
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy | Q84973156 | ||
P433 | issue | 3 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | R146 | |
P577 | publication date | 2012-06-14 | |
P1433 | published in | Arthritis Research and Therapy | Q15757229 |
P1476 | title | Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus | |
P478 | volume | 14 |
Q30049107 | B-regulatory cells in autoimmunity and immune mediated inflammation |
Q27023494 | Bone cell communication factors and Semaphorins |
Q59806580 | Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis |
Q34560081 | Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis |
Q39034598 | Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis |
Q52562276 | Emerging role of semaphorin-3A in autoimmune diseases. |
Q41884505 | Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction |
Q88361933 | Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis |
Q52148517 | Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions. |
Q38875380 | FoxP3 Expression in Macrophages, Cancer, and B Cells-Is It Real? |
Q37696987 | Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A. |
Q38169718 | Immunological functions of the neuropilins and plexins as receptors for semaphorins |
Q34395293 | Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study |
Q42181770 | Leptin increases blood pressure and markers of endothelial activation during pregnancy in rats. |
Q92798243 | Negative Regulation of Semaphorin-3A Expression in Peripheral Blood Mononuclear Cells Using MicroRNA-497-5p |
Q30415837 | Neuropilin-1 in transplantation tolerance. |
Q64060946 | Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma |
Q38192834 | Semaphorin 3A: A new player in bone remodeling |
Q58040981 | Semaphorin 3A: an immunoregulator in systemic sclerosis |
Q37275562 | Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications. |
Q47199353 | Semaphorin-3A as An Immune Modulator Is Suppressed by MicroRNA-145-5p |
Q55399992 | Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis. |
Q54235471 | Semaphorin3A: A potential therapeutic tool in immune-mediated diseases. |
Q35532272 | Semaphorin3a promotes advanced diabetic nephropathy |
Q37711201 | Semaphorin3a signaling, podocyte shape, and glomerular disease |
Q90639858 | Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets? |
Q38080487 | Semaphorins: their dual role in regulating immune-mediated diseases |
Q35610857 | The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). |
Q37670418 | The Role of Semaphorin 3A in Bone Remodeling. |
Q90164304 | Urinary Neuropilin-1: A Predictive Biomarker for Renal Outcome in Lupus Nephritis |
Search more.